Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.

Slides:



Advertisements
Similar presentations
Urine Potassium Excretion, Kidney Failure, and Mortality in CKD
Advertisements

Volume 66, Issue 1, Pages (July 2004)
Influence of Body Mass Index on Long-Term Survival After Cardiac Catheterization  Barak Zafrir, MD, Ronen Jaffe, MD, Ronen Rubinshtein, MD, Basheer Karkabi,
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
In Reply to ‘The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis’  Emily J. See, MBBS, David W. Johnson, PhD, Yeoungjee.
Independent Community House Hemodialysis as a Novel Dialysis Setting: An Observational Cohort Study  Mark R. Marshall, BHB, MBChB, FRACP, MPH (Hons),
Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes  Eduardo Lacson, MD, MPH, Weiling Wang,
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
Risk of ESRD and Mortality in Kidney and Bladder Stone Formers
Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort  Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.
Cardiovascular Disease and CKD: Core Curriculum 2010
Impact of Comorbidities on Mortality in Managed Care Patients With CKD
Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study  Rebecca A. Spicer, MBChB, Philip A. Clayton,
Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort  Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.
Quiz Page July 2009 American Journal of Kidney Diseases
Impact of Electronic Acute Kidney Injury (AKI) Alerts With Automated Nephrologist Consultation on Detection and Severity of AKI: A Quality Improvement.
IP155. Transplant Wait Listing Attenuates the Association Between Hemodialysis Access and Mortality  Courtenay Holscher, Sunjae Bae, Christine Haugen,
Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)  Richard.
Insights From the 2016 Peer Kidney Care Initiative Report: Still a Ways to Go to Improve Care for Dialysis Patients  James B. Wetmore, Suying Li, Julia.
Anne M. Butler, PhD, Andrew F. Olshan, PhD, Abhijit V
William S. Asch, Margaret J. Bia  Advances in Chronic Kidney Disease 
Evaluation of the Potential Living Kidney Donor
Interaction of Physical Activity and Body Mass Index on Mortality in Coronary Heart Disease: Data from the Nord-Trøndelag Health Study  Trine Moholdt,
Volume 88, Issue 2, Pages (August 2015)
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Molly E. Waring, PhD, Jane S
Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis  Connie M. Rhee, MD, MSc, Csaba P. Kovesdy,
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD  Rachael L. Morton, PhD, Iryna Schlackow, DPhil, Natalie Staplin, PhD, Alastair.
Perspectives of Transplant Physicians and Surgeons on Reimbursement, Compensation, and Incentives for Living Kidney Donors  Allison Tong, PhD, Jeremy.
Lifetime Incidence of CKD Stages 3-5 in the United States
American Journal of Kidney Diseases
Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients  Fowzia Ibrahim, MSc, Lisa Hamzah, MRCP, Rachael.
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.
Genetic Variation in GSTP1, Lung Function, Risk of Lung Cancer, and Mortality  Marianne S. Nørskov, MSc, PhD, Morten Dahl, MD, DMSc, Anne Tybjærg-Hansen,
The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population  Claudine T. Jurkovitz, MD, MPH, Yang Qiu,
Yousef Rezaei, MD  American Journal of Kidney Diseases 
David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD 
Volume 68, Issue 5, Pages (November 2005)
Volume 77, Issue 7, Pages (April 2010)
Stephen P. McDonald  Kidney International Supplements 
Cardiovascular Risk Assessment Among Potential Kidney Transplant Candidates: Approaches and Controversies  Krista L. Lentine, MD, MS, Frank P. Hurst,
Beef Tea, Vitality, Creatinine, and the Estimated GFR
Christina L. Klein, MD, Daniel C. Brennan, MD, FACP 
American Journal of Kidney Diseases
Quiz Page April 2008 American Journal of Kidney Diseases
Drug Dose Adjustments in Patients With Renal Impairment
Erratum American Journal of Kidney Diseases
Volume 92, Issue 2, Pages (August 2017)
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target    American.
Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies  Charuhas V. Thakar, MD  American Journal.
Volume 84, Issue 4, Pages (October 2013)
Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.
Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm  David P. Calfee, MD, MS  American Journal of Kidney.
Volume 82, Issue 3, Pages (August 2012)
Erratum American Journal of Kidney Diseases
Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System  Supreet Sethi, Reiad Najjar, Alice Peng, James.
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Volume 75, Issue 1, Pages (January 2009)
American Journal of Kidney Diseases
Guidance for the use of bilateral internal thoracic arteries according to survival benefit across age groups  Umberto Benedetto, MD, PhD, Mohamed Amrani,
Volume 87, Issue 3, Pages (March 2015)
Sushrut S. Waikar, MD, MPH, Gary C. Curhan, MD, ScD, Steven M
American Journal of Kidney Diseases
Quiz Page January 2010 American Journal of Kidney Diseases
A Randomized Controlled Trial of Coiled Versus Straight Swan-Neck Tenckhoff Catheters in Peritoneal Dialysis Patients  David W. Johnson, PhD, Jennifer.
Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients  Colin R. Lenihan, MB BCh, PhD, Sumi Sukumaran Nair, MD, Chandan Vangala,
American Journal of Kidney Diseases
Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes  Diana Mina, Kirsten L. Johansen, Charles E. McCulloch,
Catheter Type, Placement, and Insertion Techniques for Preventing Catheter-Related Infections in Maintenance Peritoneal Dialysis Patients: Summary of.
Jacob J.E. Koopman, MD, PhD  American Journal of Kidney Diseases 
Presentation transcript:

Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney Transplantation: A Population Cohort Study  Wai H. Lim, David W. Johnson, Carmel M. Hawley, Elaine Pascoe, Germaine Wong  American Journal of Kidney Diseases  Volume 71, Issue 1, Pages 102-111 (January 2018) DOI: 10.1053/j.ajkd.2017.08.018 Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Cumulative incidence function curves of (A) death-censored graft loss (DCGL) and (B) death with a functioning graft (DWFG) after kidney transplantation stratified by cumulative vascular disease burden, adjusted for the competing risk for DWFG and DCGL, respectively. American Journal of Kidney Diseases 2018 71, 102-111DOI: (10.1053/j.ajkd.2017.08.018) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Forest plots show the adjusted subdistribution hazard ratio (HR) with 95% confidence interval (95% CI) of the associations between cumulative vascular disease burden, cardiovascular disease (CVD) mortality, infection-related mortality, cancer-related mortality, and other vascular disease–related mortality. Models adjusted for donor and recipient age, waiting time, body mass index, sex, transplantation era, and race. Estimates of subdistribution HRs were derived from the competing-risk models using the Fine and Gray method. American Journal of Kidney Diseases 2018 71, 102-111DOI: (10.1053/j.ajkd.2017.08.018) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Cumulative incidence function curves of cardiovascular disease (CVD) mortality stratified by cumulative vascular disease burden, adjusted for the competing risk for non–CVD-related mortality. American Journal of Kidney Diseases 2018 71, 102-111DOI: (10.1053/j.ajkd.2017.08.018) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

Figure 4 Forest plots show adjusted hazard ratios (HRs) or adjusted subdistribution HRs with 95% confidence intervals (CIs) of the associations between cumulative vascular disease burden, all-cause mortality, overall transplant loss, death with functioning transplant, and cardiovascular disease (CVD) mortality according to pretransplantation diabetes status. Models adjusted for donor and recipient age, waiting time, body mass index, sex, transplantation era, and race. #Estimates of subdistribution HRs were derived from competing-risk models using the Fine and Gray method. American Journal of Kidney Diseases 2018 71, 102-111DOI: (10.1053/j.ajkd.2017.08.018) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions